Search research articles
Contact Us
Filters
Showing results (91-100 of 109) with videos related to
Page
of 11
Sort By:
Pain Practice : the Official Journal of World Institute of Pain
|
September 20, 2016
Altered Neural Correlates of Emotion Associated Pain Processing in Persistent Somatoform Pain Disorder: An fMRI Study
Yanli Luo, Chao Yan, Tianming Huang, et al.
Schizophrenia Research
|
February 8, 2016
Abnormal white matter microstructure in drug-naive first episode schizophrenia patients before and after eight weeks of antipsychotic treatment
Botao Zeng, Babak A Ardekani, Yingying Tang, et al.
Translational Psychiatry
|
August 11, 2021
Gut microbial biomarkers for the treatment response in first-episode, drug-naïve schizophrenia: a 24-week follow-up study
Xiuxia Yuan, Yunpeng Wang, Xue Li, et al.
Neuropsychiatric Disease and Treatment
|
June 14, 2019
Repetitive transcranial magnetic stimulation as an adjunctive treatment for negative symptoms and cognitive impairment in patients with schizophrenia: a randomized, double-blind, sham-controlled trial
Kaiming Zhuo, Yingying Tang, Zhenhua Song, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
March 15, 2020
The role of altered brain structural connectivity in resilience, vulnerability, and disease expression to schizophrenia
Qinling Wei, Ling Zhao, Yan Zou, et al.
JAMA Psychiatry
|
March 28, 2019
Efficacy and Tolerability of Adjunctive Intravenous Sodium Nitroprusside Treatment for Outpatients With Schizophrenia: A Randomized Clinical Trial
Hannah E Brown, Oliver Freudenreich, Xiaoduo Fan, et al.
Schizophrenia Research
|
September 29, 2014
A randomized placebo-controlled pilot study of pravastatin as an adjunctive therapy in schizophrenia patients: effect on inflammation, psychopathology, cognition and lipid metabolism
Brenda Vincenzi, Shannon Stock, Christina P C Borba, et al.
Human Psychopharmacology
|
March 14, 2009
Ziprasidone as an adjuvant for clozapine- or olanzapine-associated medical morbidity in chronic schizophrenia
David C Henderson, Xiaoduo Fan, Paul M Copeland, et al.
Frontiers in Psychiatry
|
November 11, 2020
Solute Carrier Family 1 (<i>SLC1A1</i>) Contributes to Susceptibility and Psychopathology Symptoms of Schizophrenia in the Han Chinese Population
Wenqiang Li, Xi Su, Tengfei Chen, et al.
Schizophrenia Research
|
December 27, 2012
Prospective memory performance in patients with drug-naïve, first-episode psychosis
Kaiming Zhuo, Yun Lu, Zhiliang Yang, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 109) with videos related to
Sort By:
Page
of 11
Pain Practice : the Official Journal of World Institute of Pain
|
September 20, 2016
Altered Neural Correlates of Emotion Associated Pain Processing in Persistent Somatoform Pain Disorder: An fMRI Study
Yanli Luo, Chao Yan, Tianming Huang, et al.
Schizophrenia Research
|
February 8, 2016
Abnormal white matter microstructure in drug-naive first episode schizophrenia patients before and after eight weeks of antipsychotic treatment
Botao Zeng, Babak A Ardekani, Yingying Tang, et al.
Translational Psychiatry
|
August 11, 2021
Gut microbial biomarkers for the treatment response in first-episode, drug-naïve schizophrenia: a 24-week follow-up study
Xiuxia Yuan, Yunpeng Wang, Xue Li, et al.
Neuropsychiatric Disease and Treatment
|
June 14, 2019
Repetitive transcranial magnetic stimulation as an adjunctive treatment for negative symptoms and cognitive impairment in patients with schizophrenia: a randomized, double-blind, sham-controlled trial
Kaiming Zhuo, Yingying Tang, Zhenhua Song, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
March 15, 2020
The role of altered brain structural connectivity in resilience, vulnerability, and disease expression to schizophrenia
Qinling Wei, Ling Zhao, Yan Zou, et al.
JAMA Psychiatry
|
March 28, 2019
Efficacy and Tolerability of Adjunctive Intravenous Sodium Nitroprusside Treatment for Outpatients With Schizophrenia: A Randomized Clinical Trial
Hannah E Brown, Oliver Freudenreich, Xiaoduo Fan, et al.
Schizophrenia Research
|
September 29, 2014
A randomized placebo-controlled pilot study of pravastatin as an adjunctive therapy in schizophrenia patients: effect on inflammation, psychopathology, cognition and lipid metabolism
Brenda Vincenzi, Shannon Stock, Christina P C Borba, et al.
Human Psychopharmacology
|
March 14, 2009
Ziprasidone as an adjuvant for clozapine- or olanzapine-associated medical morbidity in chronic schizophrenia
David C Henderson, Xiaoduo Fan, Paul M Copeland, et al.
Frontiers in Psychiatry
|
November 11, 2020
Solute Carrier Family 1 (<i>SLC1A1</i>) Contributes to Susceptibility and Psychopathology Symptoms of Schizophrenia in the Han Chinese Population
Wenqiang Li, Xi Su, Tengfei Chen, et al.
Schizophrenia Research
|
December 27, 2012
Prospective memory performance in patients with drug-naïve, first-episode psychosis
Kaiming Zhuo, Yun Lu, Zhiliang Yang, et al.
Page
of 11